Sekundärer Immundefekt bei Niereninsuffizienz am Beispiel der Hepatitis B-Impfung
- 1 September 1988
- journal article
- abstracts
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 66 (18) , 865-872
- https://doi.org/10.1007/bf01728948
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.Journal of Clinical Investigation, 1987
- Kinetic Analysis of Interleukin 2 (IL‐2) Production and Expression of IL‐2 Receptors by Uraemic and Normal LymphocytesScandinavian Journal of Immunology, 1987
- Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes MellitusNew England Journal of Medicine, 1986
- Impaired cellular immune responses in chronic renal failure: Evidence for a T cell defectKidney International, 1986
- Analysis of immune status of hemodialyzed adults: Association with prior transfusionsKidney International, 1984
- Uraemia — Does it affect host resistance to infectious disease?European Journal of Clinical Microbiology & Infectious Diseases, 1984
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- Active hepatitis B vaccination of dialysis patients and medical staffKidney International, 1984
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTSThe Lancet, 1981
- Hepatitis B Virus Markers in 97 Long-Term Hemodialysis PatientsNephron, 1979